Ascendis Pharma (spons. ADRs) Aktie
190,00
EUR
-7,00
EUR
-3,55
%
220,09
USD
-6,50
USD
-2,87
%
Werbung
Ascendis Pharma (spons. ADRs) Aktie Analyse
| 24.01.19 | Ascendis Pharma (spons. ADRs) Overweight | Cantor Fitzgerald | |
| 26.06.18 | Ascendis Pharma (spons. ADRs) Buy | Stifel, Nicolaus & Co., Inc. | |
| 26.09.16 | Ascendis Pharma (spons. ADRs) Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung